LAG3 and non-small cell lung carcinoma: However, some studies arrived at the seemingly opposite conclusion that high expression of LAG3 is associated with favorable overall survival of patients with solid tumors including ovarian, gastric, lymphoma, NSCLC, colorectal, and renal (48), as well as breast cancer.